SCHEMBL25122471

SCHEMBL25122471

NC1CN(CC(=O)OCc2ccccc2)CC1I

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ CYP2C19 P33261 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ KDM1A O60341 2/20 0.41
▸ MAOA P21397 2/20 0.41
▸ MAOB P27338 2/20 0.41
▸ RCOR1 Q9UKL0 1/20 0.40
▸ S1PR5 Q9H228 1/20 0.40
▸ KMT2A Q03164 2/20 0.39
▸ GLA P06280 1/20 0.39
▸ SLC15A1 P46059 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25122374 0.84 ALDH1A1 (0.45) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL21397345 0.82 ALDH1A1 (0.49) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL23054258 0.82 S1PR5 (0.57) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL19966271 0.80 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL19465293 0.80 SMN1; SMN2 (0.46) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL18909590 0.79 SMN1; SMN2 (0.48) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL10859364 0.78 ALDH1A1 (0.61) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL24970558 0.78 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL19604406 0.78 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL19934909 0.78 FUCA1 (0.55) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE49481-E1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease HOFFMANN-LA ROCHE INC. (US) 2023-04-04 — — US disclosed
Send feedback